Trial intelligence / Profile preview

Metformin for Recurrence in Non-Diabetic Colorectal Cancer

NCT02614339Phase 3Unknown

Sponsor
Yonsei University
Start
Dec 2015
Primary completion
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of metformin in colorectal cancer (CRC), sponsored by Yonsei University. Status: unknown.

02

Drugs

metformin
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT02614339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02614339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call